E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension
D. Yi, B. Liu, H. Ding, S. Li, R. Li, J. Pan, K. Ramirez, X. Xia, M. Kala, I. Singh, Q. Ye, W. H. Lee, R. Frye, T. Wang, Y. Zhao, , Z. Dai
This study shows that SOX17 deficiency in endothelial cells causes pulmonary hypertension via E2F1 signaling, suggesting E2F1 as a therapeutic target in PAH.
bioRxiv · Feb 15, 2023Physiology